These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1903220)

  • 1. Transient pure red cell aplasia caused by antilymphoblast globulin after cadaveric renal transplantation.
    Schaffner A; Thomann B; Zala GF; Rüegg R; Keusch G; Fehr J; Gmür J
    Transplantation; 1991 May; 51(5):1018-23. PubMed ID: 1903220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure red cell aplasia: response to therapy with anti-thymocyte globulin.
    Abkowitz JL; Powell JS; Nakamura JM; Kadin ME; Adamson JW
    Am J Hematol; 1986 Dec; 23(4):363-71. PubMed ID: 3098093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia (PRCA): Response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis.
    Marmont A; Peschle C; Sanguineti M; Condorelli M
    Blood; 1975 Feb; 45(2):247-61. PubMed ID: 1078982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of idiopathic pure red cell aplasia with antithymocyte globulin].
    Soda M; Usuki K; Adachi Y; Kazama H; Iki S; Urabe A
    Rinsho Ketsueki; 2001 Nov; 42(11):1122-7. PubMed ID: 11808082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient response of pure red cell aplasia to anti-thymocyte globulin in a patient with T-cell chronic lymphocytic leukemia.
    Hocking W; Champlin R; Mitsuyasu R
    Am J Hematol; 1987 Mar; 24(3):285-91. PubMed ID: 3103427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes and antibody in retrovirus-induced feline pure red cell aplasia.
    Abkowitz JL; Ott RL; Holly RD; Adamson JW
    J Natl Cancer Inst; 1987 Jan; 78(1):135-9. PubMed ID: 3025500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
    Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
    Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality of acquired primary pure red cell aplasia: effectiveness of antithymocyte globulin.
    Dinçol G; Aktan M; Nalçaci M; Yavuz AS; Keskin H; Dawson B; Dinçol K
    Leuk Lymphoma; 2001; 42(6):1413-7. PubMed ID: 11911428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure red cell aplasia following autoimmune haemolytic anaemia. Cell-mediated suppression of erythropoiesis as a possible pathogenesis of pure red cell aplasia.
    Tohda S; Nara N; Tanikawa S; Imai Y; Murakami N; Aoki N
    Acta Haematol; 1992; 87(1-2):98-102. PubMed ID: 1585778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors.
    Najarian JS; Simmons RL; Condie RM; Thompson EJ; Fryd DS; Howard RJ; Matas AJ; Sutherland DE; Ferguson RM; Schmidtke JR
    Ann Surg; 1976 Sep; 184(3):352-68. PubMed ID: 786192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: correlation with in vitro erythroid culture studies.
    Mangan KF; Shadduck RK
    Am J Hematol; 1984; 17(4):417-26. PubMed ID: 6238526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from pure red cell aplasia caused by anti-erythropoietin antibodies after kidney transplantation.
    Snanoudj R; Beaudreuil S; Arzouk N; Jacq D; Casadevall N; Charpentier B; Durrbach A
    Am J Transplant; 2004 Feb; 4(2):274-7. PubMed ID: 14974951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum erythropoietic inhibitors in patients with pure red cell aplasia.
    Takahashi M; Nikkuni K; Tanaka I; Furukawa T; Moriyama Y; Shibata A; Satoh S; Kuwabara Y; Maruyama Y; Matsunaga Y
    Ann Hematol; 1991 Jul; 63(1):9-14. PubMed ID: 1908708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyserythropoiesis and erythroblast-phagocytosis preceding pure red cell aplasia.
    Keefer MJ; Solanki DL
    Am J Hematol; 1988 Feb; 27(2):132-5. PubMed ID: 3124607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia characterized by erythropoietic maturation arrest. Response to anti-thymocyte globulin.
    Jacobs AD; Champlin RE; Golde DW
    Am J Med; 1985 Mar; 78(3):515-7. PubMed ID: 3919580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is antibody-mediated pure red cell aplasia (PRCA)?
    Casadevall N
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
    Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
    Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.